Hbk Investments L P Vanda Pharmaceuticals Inc. Transaction History

Hbk Investments L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$17.59 - $31.05 $1.14 Million - $2.01 Million	-64,782 Reduced 30.41%	148,217 $2.73 Million
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $108,185 - $179,473	5,703 Added 2.75%	212,999 $5.57 Million
Q3 2018 Nov 14, 2018	BUY	$18.25 - $23.0 $291,489 - $367,356	15,972 Added 8.35%	207,296 $4.76 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $19.15 $1.24 Million - $1.7 Million	89,024 Added 87.02%	191,324 $3.65 Million
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $799,445 - $1.15 Million	56,900 Added 125.33%	102,300 $1.72 Million
Q4 2017 Feb 14, 2018	SELL	$12.85 - $18.1 $259,570 - $365,620	-20,200 Reduced 30.79%	45,400 $690,000
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $1.01 Million - $1.24 Million	65,600	65,600 $1.17 Million

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $244M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.